SNBL to acquire Satsuma Pharma
SNBL will be involved in the launch of novel intranasal drug, which was developed based on SNBL’s novel intranasal drug delivery platform technology
SNBL | 21/04/2023 | By Sudeep Soparkar | 269
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy